Zhejiang Xinhua Chemical Co.,Ltd (603867.SS)
CNY 23.17
(0.83%)
CNY 23.17
(0.83%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 281.42 Million | 322.93 Million | 55.04 Million | 95.3 Million | 235.64 Million | 205.75 Million |
| Net Income | 288.77 Million | 369.6 Million | 210.25 Million | 222.69 Million | 126.22 Million | 188.74 Million |
| Depreciation & Amortization | 99.53 Million | 97.2 Million | 85.16 Million | 84.31 Million | 83.08 Million | 62.42 Million |
| Deferred income taxes | 1.66 Million | -2.27 Million | 1.06 Million | 9.02 Million | 14.73 Million | - |
| Stock-based compensation | - | 4.56 Million | 10.44 Million | 704.3 Thousand | - | - |
| Change in working capital | -126.05 Million | -141.57 Million | -252.89 Million | -202.71 Million | 47.9 Million | -69.86 Million |
| Other non-cash items | 21.06 Million | -4.59 Million | 1.01 Million | -18.7 Million | -21.56 Million | 24.46 Million |
| Investing Cash Flow | -206.72 Million | -551.17 Million | 84.53 Million | -31.84 Million | -541.9 Million | -50.36 Million |
| Investments in PPE | -384.02 Million | -520.04 Million | -261.45 Million | -129.46 Million | -76.26 Million | -50.78 Million |
| Acquisitions | 20.46 Million | 2.62 Million | 91.39 Million | 55.24 Million | 77.89 Thousand | 426.09 Thousand |
| Investment purchases | -66.85 Million | - | -2.5 Million | -1.81 Billion | -592.2 Million | - |
| Sales/Maturities of investments | 4.53 Million | 8.9 Million | 9.1 Million | 18.87 Million | 779.4 Thousand | - |
| Other Investing Activities | 239 Million | -42.66 Million | 248 Million | 1.83 Billion | 125.7 Million | 426.09 Thousand |
| Financing Cash Flow | -26.91 Million | 489.69 Million | -47.98 Million | -12.95 Million | 294.72 Million | -46.76 Million |
| Debt repayment | -37.13 Million | -597.02 Million | -152.2 Million | -111.26 Million | -267.27 Million | -384.68 Million |
| Dividends payments | -102.07 Million | -70.88 Million | -63.4 Million | -35 Million | -35 Million | -36.74 Million |
| Common Stock Repurchased | - | - | - | -12.1 Million | -522.15 Million | - |
| Common Stock Issuance | - | - | - | 12.1 Million | 522.15 Million | - |
| Other Financing Activities | 43.8 Million | 1.17 Billion | 173.59 Million | 140.57 Million | 605.82 Million | 374.66 Million |
| Accounts receivables | -93.2 Million | -150.05 Million | -217.9 Million | -269.15 Million | -42.6 Million | -19.81 Million |
| Accounts payables | -26.8 Million | -614.41 Thousand | 33.68 Million | 65.19 Million | 65.98 Million | - |
| Inventory | -7.7 Million | 11.36 Million | -69.73 Million | -7.77 Million | 9.78 Million | -31.52 Million |
| Other working capital | -2.35 Million | -2.27 Million | 1.06 Million | 9.02 Million | 14.73 Million | -38.33 Million |
| Cash at beginning of period | 678.66 Million | 409.44 Million | 321.12 Million | 276.57 Million | 285.71 Million | 178.49 Million |
| Cash at end of period | 729.57 Million | 678.66 Million | 409.44 Million | 321.12 Million | 276.57 Million | 285.71 Million |
| Capital Expenditure | -384.02 Million | -520.04 Million | -261.45 Million | -129.46 Million | -76.26 Million | -50.78 Million |
| Effect of forex changes on cash | 3.13 Million | 7.76 Million | -3.27 Million | -5.95 Million | 2.39 Million | -1.41 Million |
| Net cash flow / Change in cash | 50.91 Million | 269.21 Million | 88.31 Million | 44.55 Million | -9.13 Million | 107.21 Million |
| Free Cash Flow | -102.6 Million | -197.11 Million | -206.4 Million | -34.15 Million | 159.38 Million | 154.96 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 33.04 Million | 71.05 Million | 76.11 Million | 288.77 Million | 48.3 Million | 66.38 Million |
| Depreciation & Amortization | - | 26.77 Million | 26.77 Million | 99.53 Million | 25.56 Million | -48.24 Million |
| Deferred income taxes | - | - | - | 1.66 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -126.91 Million | - | -126.05 Million | -103.27 Million | 38.48 Million |
| Other non-cash items | 68.12 Million | 9.88 Million | -82.63 Million | 21.06 Million | 26.98 Million | 30.95 Million |
| Investing Cash Flow | -73.71 Million | -38.69 Million | -48.79 Million | -206.72 Million | -173.96 Million | -120.38 Million |
| Investments in PPE | -43.41 Million | -49.84 Million | -76.77 Million | -384.02 Million | -126.92 Million | -111.38 Million |
| Acquisitions | 288 Thousand | 11.14 Million | 27.97 Million | 20.46 Million | 113.42 Thousand | 4.9 Million |
| Investment purchases | -30.59 Million | - | - | -66.85 Million | -51.35 Million | -9 Million |
| Sales/Maturities of investments | - | - | - | 4.53 Million | 3.69 Million | -239 Million |
| Other Investing Activities | - | 303.3 Thousand | - | 239 Million | -239 Million | 234.1 Million |
| Financing Cash Flow | -24.55 Million | -71.35 Million | -75.2 Million | -26.91 Million | 76.29 Million | -12.85 Million |
| Debt repayment | -8.14 Million | -12.59 Million | -13.84 Million | -37.13 Million | -79.62 Million | -70 Million |
| Dividends payments | - | -83.73 Million | -1.37 Million | -102.07 Million | -102.07 Million | -837.99 Thousand |
| Common Stock Repurchased | 59.99 Million | -6419.44 | -59.99 Million | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -92.69 Million | -83.93 Million | -1.37 Million | 43.8 Million | -674.83 Thousand | 57.97 Million |
| Accounts receivables | - | -111.48 Million | - | -93.2 Million | -93.2 Million | 1.72 Million |
| Accounts payables | - | - | - | -26.8 Million | - | 445 Thousand |
| Inventory | - | -17.57 Million | - | -7.7 Million | -7.7 Million | 36.76 Million |
| Other working capital | - | 2.14 Million | - | -2.35 Million | -2.35 Million | -445 Thousand |
| Cash at beginning of period | 561.28 Million | 606.01 Million | 784.28 Million | 678.66 Million | 779.63 Million | 824.56 Million |
| Cash at end of period | 573.2 Million | 561.28 Million | 606.01 Million | 729.57 Million | 729.57 Million | 779.63 Million |
| Capital Expenditure | -43.41 Million | -49.84 Million | -76.77 Million | -384.02 Million | -126.92 Million | -111.38 Million |
| Effect of forex changes on cash | - | 3.3 Million | 2.75 Million | 3.13 Million | 1.59 Million | 747.04 Thousand |
| Net cash flow / Change in cash | 11.92 Million | -44.72 Million | -178.27 Million | 50.91 Million | -50.05 Million | -44.92 Million |
| Free Cash Flow | 57.75 Million | 4.32 Million | -83.28 Million | -102.6 Million | -77.2 Million | -23.81 Million |
2185
DKS
MREO
SMSPHARMA
STLJF
HEMP